Experience

Flamingo Therapeutics

• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • 2023 - Present

  Offices in Belgium, France, USA Flamingo is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline, including Phase II trial PEMDA-HN evaluating the STAT3 targeting agent danvatirsen, in combination with pembrolizumab, in patients with head and neck squamous cell carcinoma (HNSCC). Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known European and US biotechnology investors.



Dynacure

• France
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer (Dynacure merged with Flamingo Therapeutics in 2023)

  • 2016 - 2023

  Strasbourg Area, France. Philadelphia, PA USA Dynacure was a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure was developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals.



Confo Therapeutics

• Belgium
• Biotechnology
• 1 - 100 Employee

• CEO

  • 2014 - 2016

  Brussels Area, Belgium Confo Therapeutics is a drug discovery company building a portfolio of development programs by employing its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs (G protein-coupled receptors) as a superior starting point for drug discovery in CONFO® body-stabilized active state conformations of these receptors to uncover a wide range of previously inaccessible drug targets.



ViroPharma Incorporated - acquired by Shire in 2014

• Director

  • 2012 - 2014

  Maidenhead, London



Genzyme, a Sanofi Division

• Senior Director Cardiovascular Europe - Rare Diseases Division

  • 2006 - 2012

  Amsterdam Area, Netherlands

• Director Commercial Development and Finance

  • 2005 - 2006


Arthur D. Little
• Belgium
• Business Consulting and Services
• 700 & Above Employee
• Manager

  • 1996 - 2004

MD
• United Kingdom
• Performing Arts
• Medical practice

  • 1994 - 1996